SAP SE (LON:0NW4)

Market Cap	252.66B
Revenue (ttm)	30.76B
Net Income (ttm)	5.61B
Shares Out	n/a
EPS (ttm)	4.76
PE Ratio	45.06
Forward PE	39.13
Dividend	1.98 (0.78%)
Ex-Dividend Date	May 14, 2025

Volume	516,631
Average Volume	490,033
Open	249.20
Previous Close	250.91
Day's Range	242.85 - 249.95
52-Week Range	176.78 - 283.40
Beta	0.94
RSI	38.72
Earnings Date	Jul 22, 2025

About Revance Therapeutics

SAP SE, together with its subsidiaries, provides enterprise application and business solutions worldwide. It offers SAP S/4HANA that provides software capabilities for finance, risk and project management, procurement, manufacturing, supply chain and asset management, and research and development; SAP SuccessFactors solutions for human resources, including HR, time, payroll, talent and employee experience management, and analytics and planning; and spend management solutions that covers direct and indirect spend, travel and expense, and externa...

• Industry: Prepackaged Software
• Founded: 1972
• Employees: 109,121
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NW4

Financial Performance

In 2024, SAP SE's revenue was 34.18 billion, an increase of 9.51% compared to the previous year's 31.21 billion. Earnings were 3.12 billion, a decrease of -49.11%.